Vetinel is developed through the biotechnology expertise of Allegene Pharmalabs, combining human-grade biologic workflows and technologies adapted for veterinary medicine.
150000+
Cases treated since 2021
25+
Years of research
12
Patents & applications
35
Registered Trademarks
4
Commercial Brands
A new Standard in Veterinary Regeneration
Human-grade European Manufacturing
Closed. Sterile. Controlled.
Preserving biologic integrity throughout the regenerative process
Proven in Performance
Across Species
Equine, companion animal, camelid and livestock applications.
